JPH10245331A - Preparation for external use for skin - Google Patents
Preparation for external use for skinInfo
- Publication number
- JPH10245331A JPH10245331A JP6246597A JP6246597A JPH10245331A JP H10245331 A JPH10245331 A JP H10245331A JP 6246597 A JP6246597 A JP 6246597A JP 6246597 A JP6246597 A JP 6246597A JP H10245331 A JPH10245331 A JP H10245331A
- Authority
- JP
- Japan
- Prior art keywords
- acid
- skin
- effect
- preparation
- molecular
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 32
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 claims abstract description 25
- 229920001296 polysiloxane Polymers 0.000 claims abstract description 20
- 150000003839 salts Chemical class 0.000 claims abstract description 14
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 12
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims abstract description 12
- 150000002148 esters Chemical class 0.000 claims abstract description 11
- 150000002596 lactones Chemical class 0.000 claims abstract description 10
- 239000002253 acid Substances 0.000 claims abstract description 8
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 claims abstract description 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract description 5
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims abstract description 3
- 150000007513 acids Chemical class 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 36
- -1 polysiloxane Polymers 0.000 abstract description 22
- 229960003237 betaine Drugs 0.000 abstract description 9
- 239000004205 dimethyl polysiloxane Substances 0.000 abstract description 5
- 235000013870 dimethyl polysiloxane Nutrition 0.000 abstract description 5
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 abstract description 5
- 102000011782 Keratins Human genes 0.000 abstract description 3
- 108010076876 Keratins Proteins 0.000 abstract description 3
- 125000003944 tolyl group Chemical group 0.000 abstract 2
- 210000003491 skin Anatomy 0.000 description 44
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 14
- 206010013786 Dry skin Diseases 0.000 description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 13
- 230000000052 comparative effect Effects 0.000 description 13
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 230000003020 moisturizing effect Effects 0.000 description 10
- 239000000126 substance Substances 0.000 description 10
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 8
- 230000003405 preventing effect Effects 0.000 description 8
- 239000003921 oil Substances 0.000 description 7
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- 238000011156 evaluation Methods 0.000 description 6
- 235000019198 oils Nutrition 0.000 description 6
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 5
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 5
- 235000010323 ascorbic acid Nutrition 0.000 description 5
- 229960005070 ascorbic acid Drugs 0.000 description 5
- 239000011668 ascorbic acid Substances 0.000 description 5
- 235000015165 citric acid Nutrition 0.000 description 5
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 5
- 238000001704 evaporation Methods 0.000 description 5
- 230000008020 evaporation Effects 0.000 description 5
- 239000008213 purified water Substances 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 4
- 206010040844 Skin exfoliation Diseases 0.000 description 4
- 229920002125 Sokalan® Polymers 0.000 description 4
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 239000004310 lactic acid Substances 0.000 description 4
- 235000014655 lactic acid Nutrition 0.000 description 4
- 239000001630 malic acid Substances 0.000 description 4
- 235000011090 malic acid Nutrition 0.000 description 4
- LXCFILQKKLGQFO-UHFFFAOYSA-N p-hydroxybenzoic acid methyl ester Natural products COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- 239000008346 aqueous phase Substances 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 239000002537 cosmetic Substances 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 238000004299 exfoliation Methods 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 3
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 3
- 229960002216 methylparaben Drugs 0.000 description 3
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- FFJCNSLCJOQHKM-CLFAGFIQSA-N (z)-1-[(z)-octadec-9-enoxy]octadec-9-ene Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCCCCCCC\C=C/CCCCCCCC FFJCNSLCJOQHKM-CLFAGFIQSA-N 0.000 description 2
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 2
- WHBMMWSBFZVSSR-UHFFFAOYSA-N 3-hydroxybutyric acid Chemical compound CC(O)CC(O)=O WHBMMWSBFZVSSR-UHFFFAOYSA-N 0.000 description 2
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 2
- JRLTTZUODKEYDH-UHFFFAOYSA-N 8-methylquinoline Chemical group C1=CN=C2C(C)=CC=CC2=C1 JRLTTZUODKEYDH-UHFFFAOYSA-N 0.000 description 2
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 2
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
- 239000004166 Lanolin Substances 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 229930003779 Vitamin B12 Natural products 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- KVYGGMBOZFWZBQ-UHFFFAOYSA-N benzyl nicotinate Chemical compound C=1C=CN=CC=1C(=O)OCC1=CC=CC=C1 KVYGGMBOZFWZBQ-UHFFFAOYSA-N 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 229960000541 cetyl alcohol Drugs 0.000 description 2
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- ROBFUDYVXSDBQM-UHFFFAOYSA-N hydroxymalonic acid Chemical compound OC(=O)C(O)C(O)=O ROBFUDYVXSDBQM-UHFFFAOYSA-N 0.000 description 2
- 235000019388 lanolin Nutrition 0.000 description 2
- 229940039717 lanolin Drugs 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- 239000000845 maltitol Substances 0.000 description 2
- 235000010449 maltitol Nutrition 0.000 description 2
- 229940035436 maltitol Drugs 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 229940055726 pantothenic acid Drugs 0.000 description 2
- 235000019161 pantothenic acid Nutrition 0.000 description 2
- 239000011713 pantothenic acid Substances 0.000 description 2
- 235000019271 petrolatum Nutrition 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 235000017709 saponins Nutrition 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 210000000434 stratum corneum Anatomy 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 235000002906 tartaric acid Nutrition 0.000 description 2
- 239000011975 tartaric acid Substances 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000019163 vitamin B12 Nutrition 0.000 description 2
- 239000011715 vitamin B12 Substances 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- 230000004580 weight loss Effects 0.000 description 2
- WGVKWNUPNGFDFJ-DQCZWYHMSA-N β-tocopherol Chemical compound OC1=CC(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C WGVKWNUPNGFDFJ-DQCZWYHMSA-N 0.000 description 2
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 description 1
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 1
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 1
- NWCHELUCVWSRRS-SECBINFHSA-N (2r)-2-hydroxy-2-phenylpropanoic acid Chemical compound OC(=O)[C@@](O)(C)C1=CC=CC=C1 NWCHELUCVWSRRS-SECBINFHSA-N 0.000 description 1
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 1
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- OTOIIPJYVQJATP-BYPYZUCNSA-N (R)-pantoic acid Chemical compound OCC(C)(C)[C@@H](O)C(O)=O OTOIIPJYVQJATP-BYPYZUCNSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- AZNRMKYTAHHKAC-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OC(CO)CO AZNRMKYTAHHKAC-UHFFFAOYSA-N 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N 1,8-cineole Natural products C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- BFPYWIDHMRZLRN-UHFFFAOYSA-N 17alpha-ethynyl estradiol Natural products OC1=CC=C2C3CCC(C)(C(CC4)(O)C#C)C4C3CCC2=C1 BFPYWIDHMRZLRN-UHFFFAOYSA-N 0.000 description 1
- ZXDDPOHVAMWLBH-UHFFFAOYSA-N 2,4-Dihydroxybenzophenone Chemical compound OC1=CC(O)=CC=C1C(=O)C1=CC=CC=C1 ZXDDPOHVAMWLBH-UHFFFAOYSA-N 0.000 description 1
- DJCYDDALXPHSHR-UHFFFAOYSA-N 2-(2-propoxyethoxy)ethanol Chemical compound CCCOCCOCCO DJCYDDALXPHSHR-UHFFFAOYSA-N 0.000 description 1
- AFENDNXGAFYKQO-UHFFFAOYSA-N 2-hydroxybutyric acid Chemical compound CCC(O)C(O)=O AFENDNXGAFYKQO-UHFFFAOYSA-N 0.000 description 1
- MUHFRORXWCGZGE-KTKRTIGZSA-N 2-hydroxyethyl (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCCO MUHFRORXWCGZGE-KTKRTIGZSA-N 0.000 description 1
- BWLBGMIXKSTLSX-UHFFFAOYSA-N 2-hydroxyisobutyric acid Chemical compound CC(C)(O)C(O)=O BWLBGMIXKSTLSX-UHFFFAOYSA-N 0.000 description 1
- KNUPSOXBESCJLY-UHFFFAOYSA-N 2-methoxy-1-phenylhexan-1-one Chemical compound CCCCC(OC)C(=O)C1=CC=CC=C1 KNUPSOXBESCJLY-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- JHPNVNIEXXLNTR-UHFFFAOYSA-N 4-(trimethylammonio)butanoate Chemical compound C[N+](C)(C)CCCC([O-])=O JHPNVNIEXXLNTR-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- 229940090248 4-hydroxybenzoic acid Drugs 0.000 description 1
- XZIIFPSPUDAGJM-UHFFFAOYSA-N 6-chloro-2-n,2-n-diethylpyrimidine-2,4-diamine Chemical compound CCN(CC)C1=NC(N)=CC(Cl)=N1 XZIIFPSPUDAGJM-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- 241000086254 Arnica montana Species 0.000 description 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 1
- 240000006891 Artemisia vulgaris Species 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 235000018185 Betula X alpestris Nutrition 0.000 description 1
- 235000018212 Betula X uliginosa Nutrition 0.000 description 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
- VWZNCPMQBFJSPH-VKBSETNNSA-N C1[C@H](C([C@@H](CC1(C(=O)O)O)O)O)O.C(C(=O)C)(=O)O Chemical compound C1[C@H](C([C@@H](CC1(C(=O)O)O)O)O)O.C(C(=O)C)(=O)O VWZNCPMQBFJSPH-VKBSETNNSA-N 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 241000283153 Cetacea Species 0.000 description 1
- 241000422842 Chamaecyparis pisifera Species 0.000 description 1
- XFTRTWQBIOMVPK-YFKPBYRVSA-N Citramalic acid Natural products OC(=O)[C@](O)(C)CC(O)=O XFTRTWQBIOMVPK-YFKPBYRVSA-N 0.000 description 1
- 240000005109 Cryptomeria japonica Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- 229930182843 D-Lactic acid Natural products 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- RGHNJXZEOKUKBD-MGCNEYSASA-N D-galactonic acid Chemical compound OC[C@@H](O)[C@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-MGCNEYSASA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- PHOQVHQSTUBQQK-SQOUGZDYSA-N D-glucono-1,5-lactone Chemical compound OC[C@H]1OC(=O)[C@H](O)[C@@H](O)[C@@H]1O PHOQVHQSTUBQQK-SQOUGZDYSA-N 0.000 description 1
- JVTAAEKCZFNVCJ-UWTATZPHSA-N D-lactic acid Chemical compound C[C@@H](O)C(O)=O JVTAAEKCZFNVCJ-UWTATZPHSA-N 0.000 description 1
- CUOKHACJLGPRHD-BXXZVTAOSA-N D-ribono-1,4-lactone Chemical compound OC[C@H]1OC(=O)[C@H](O)[C@@H]1O CUOKHACJLGPRHD-BXXZVTAOSA-N 0.000 description 1
- ODBLHEXUDAPZAU-ZAFYKAAXSA-N D-threo-isocitric acid Chemical compound OC(=O)[C@H](O)[C@@H](C(O)=O)CC(O)=O ODBLHEXUDAPZAU-ZAFYKAAXSA-N 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical class S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- BFPYWIDHMRZLRN-SLHNCBLASA-N Ethinyl estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 BFPYWIDHMRZLRN-SLHNCBLASA-N 0.000 description 1
- XXRCUYVCPSWGCC-UHFFFAOYSA-N Ethyl pyruvate Chemical compound CCOC(=O)C(C)=O XXRCUYVCPSWGCC-UHFFFAOYSA-N 0.000 description 1
- WEEGYLXZBRQIMU-WAAGHKOSSA-N Eucalyptol Chemical compound C1C[C@H]2CC[C@]1(C)OC2(C)C WEEGYLXZBRQIMU-WAAGHKOSSA-N 0.000 description 1
- 240000001972 Gardenia jasminoides Species 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 1
- ODBLHEXUDAPZAU-FONMRSAGSA-N Isocitric acid Natural products OC(=O)[C@@H](O)[C@H](C(O)=O)CC(O)=O ODBLHEXUDAPZAU-FONMRSAGSA-N 0.000 description 1
- NGEWQZIDQIYUNV-UHFFFAOYSA-N L-valinic acid Natural products CC(C)C(O)C(O)=O NGEWQZIDQIYUNV-UHFFFAOYSA-N 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- 241000234435 Lilium Species 0.000 description 1
- 235000003956 Luffa Nutrition 0.000 description 1
- 244000050983 Luffa operculata Species 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- 240000000982 Malva neglecta Species 0.000 description 1
- 235000000060 Malva neglecta Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- JSCQSBGXKRTPHZ-UHFFFAOYSA-N Mucidin Natural products COC=C(C(=O)OC)C(C)=CC=CC1=CC=CC=C1 JSCQSBGXKRTPHZ-UHFFFAOYSA-N 0.000 description 1
- AOMUHOFOVNGZAN-UHFFFAOYSA-N N,N-bis(2-hydroxyethyl)dodecanamide Chemical compound CCCCCCCCCCCC(=O)N(CCO)CCO AOMUHOFOVNGZAN-UHFFFAOYSA-N 0.000 description 1
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 1
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N N-methylaminoacetic acid Natural products C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241000736199 Paeonia Species 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- RVSTWRHIGKXTLG-UHFFFAOYSA-N Pangamic acid Natural products CC(C)N(C(C)C)C(N(C(C)C)C(C)C)C(=O)OCC(O)C(O)C(O)C(O)C(O)=O RVSTWRHIGKXTLG-UHFFFAOYSA-N 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 1
- 241000218657 Picea Species 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 235000019774 Rice Bran oil Nutrition 0.000 description 1
- KYWSCMDFVARMPN-LCSVLAELSA-N Saikosaponin D Chemical compound O([C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@]([C@H]3[C@]([C@@H]4[C@@]([C@@]5(C[C@@H](O)[C@]67CO[C@]5([C@@H]6CC(C)(C)CC7)C=C4)C)(C)CC3)(C)CC2)(C)CO)O[C@@H]([C@@H]1O)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O KYWSCMDFVARMPN-LCSVLAELSA-N 0.000 description 1
- 108010077895 Sarcosine Proteins 0.000 description 1
- 244000288377 Saxifraga stolonifera Species 0.000 description 1
- 235000002953 Saxifraga stolonifera Nutrition 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 239000004147 Sorbitan trioleate Substances 0.000 description 1
- PRXRUNOAOLTIEF-ADSICKODSA-N Sorbitan trioleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCC\C=C/CCCCCCCC)[C@H]1OC[C@H](O)[C@H]1OC(=O)CCCCCCC\C=C/CCCCCCCC PRXRUNOAOLTIEF-ADSICKODSA-N 0.000 description 1
- 240000006394 Sorghum bicolor Species 0.000 description 1
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- VBIIFPGSPJYLRR-UHFFFAOYSA-M Stearyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)C VBIIFPGSPJYLRR-UHFFFAOYSA-M 0.000 description 1
- JSCQSBGXKRTPHZ-WMSPMLHYSA-N Strobilurin A Natural products COC=C(/C(=C/C=C/c1ccccc1)/C)C(=O)OC JSCQSBGXKRTPHZ-WMSPMLHYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- LXNHXLLTXMVWPM-UHFFFAOYSA-N Vitamin B6 Natural products CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 1
- 229930003756 Vitamin B7 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- UDRYFKCHZFVZGJ-UHFFFAOYSA-N [5-hexadecanoyloxy-4-(hexadecanoyloxymethyl)-6-methylpyridin-3-yl]methyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC1=CN=C(C)C(OC(=O)CCCCCCCCCCCCCCC)=C1COC(=O)CCCCCCCCCCCCCCC UDRYFKCHZFVZGJ-UHFFFAOYSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 229940062909 amyl salicylate Drugs 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- NWCHELUCVWSRRS-UHFFFAOYSA-N atrolactic acid Chemical compound OC(=O)C(O)(C)C1=CC=CC=C1 NWCHELUCVWSRRS-UHFFFAOYSA-N 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- UKXSKSHDVLQNKG-UHFFFAOYSA-N benzilic acid Chemical compound C=1C=CC=CC=1C(O)(C(=O)O)C1=CC=CC=C1 UKXSKSHDVLQNKG-UHFFFAOYSA-N 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 229960004365 benzoic acid Drugs 0.000 description 1
- 229950004580 benzyl nicotinate Drugs 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 229940066595 beta tocopherol Drugs 0.000 description 1
- 229940036350 bisabolol Drugs 0.000 description 1
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940067596 butylparaben Drugs 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- XFTRTWQBIOMVPK-UHFFFAOYSA-N citramalic acid Chemical compound OC(=O)C(O)(C)CC(O)=O XFTRTWQBIOMVPK-UHFFFAOYSA-N 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 description 1
- 150000005690 diesters Chemical class 0.000 description 1
- CXPOFJRHCFPDRI-UHFFFAOYSA-N dodecylbenzene;sulfuric acid Chemical compound OS(O)(=O)=O.CCCCCCCCCCCCC1=CC=CC=C1 CXPOFJRHCFPDRI-UHFFFAOYSA-N 0.000 description 1
- SYELZBGXAIXKHU-UHFFFAOYSA-N dodecyldimethylamine N-oxide Chemical compound CCCCCCCCCCCC[N+](C)(C)[O-] SYELZBGXAIXKHU-UHFFFAOYSA-N 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 210000001339 epidermal cell Anatomy 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 229960002568 ethinylestradiol Drugs 0.000 description 1
- NYNCZOLNVTXTTP-UHFFFAOYSA-N ethyl 2-(1,3-dioxoisoindol-2-yl)acetate Chemical compound C1=CC=C2C(=O)N(CC(=O)OCC)C(=O)C2=C1 NYNCZOLNVTXTTP-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 1
- FMMOOAYVCKXGMF-MURFETPASA-N ethyl linoleate Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(=O)OCC FMMOOAYVCKXGMF-MURFETPASA-N 0.000 description 1
- 229940031016 ethyl linoleate Drugs 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- QKLCQKPAECHXCQ-UHFFFAOYSA-N ethyl phenylglyoxylate Chemical compound CCOC(=O)C(=O)C1=CC=CC=C1 QKLCQKPAECHXCQ-UHFFFAOYSA-N 0.000 description 1
- 229940117360 ethyl pyruvate Drugs 0.000 description 1
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 1
- 235000008524 evening primrose extract Nutrition 0.000 description 1
- 239000010475 evening primrose oil Substances 0.000 description 1
- 229940089020 evening primrose oil Drugs 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 210000001061 forehead Anatomy 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- WTXGYGWMPUGBAL-MGCNEYSASA-N galactonolactone Chemical compound O[C@@H]1COC(=O)[C@H](O)[C@@H](O)[C@H]1O WTXGYGWMPUGBAL-MGCNEYSASA-N 0.000 description 1
- FODTZLFLDFKIQH-FSVGXZBPSA-N gamma-Oryzanol (TN) Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)O[C@@H]2C([C@@H]3CC[C@H]4[C@]5(C)CC[C@@H]([C@@]5(C)CC[C@@]54C[C@@]53CC2)[C@H](C)CCC=C(C)C)(C)C)=C1 FODTZLFLDFKIQH-FSVGXZBPSA-N 0.000 description 1
- 235000010382 gamma-tocopherol Nutrition 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 235000012209 glucono delta-lactone Nutrition 0.000 description 1
- 229960003681 gluconolactone Drugs 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 235000003969 glutathione Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- ACGUYXCXAPNIKK-UHFFFAOYSA-N hexachlorophene Chemical compound OC1=C(Cl)C=C(Cl)C(Cl)=C1CC1=C(O)C(Cl)=CC(Cl)=C1Cl ACGUYXCXAPNIKK-UHFFFAOYSA-N 0.000 description 1
- 229960004068 hexachlorophene Drugs 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- VLHZUYUOEGBBJB-UHFFFAOYSA-N hydroxy stearic acid Natural products OCCCCCCCCCCCCCCCCCC(O)=O VLHZUYUOEGBBJB-UHFFFAOYSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000004491 isohexyl group Chemical group C(CCC(C)C)* 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- KFZMGEQAYNKOFK-UHFFFAOYSA-N isopropyl alcohol Natural products CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 229940089456 isopropyl stearate Drugs 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- BTNMPGBKDVTSJY-UHFFFAOYSA-N keto-phenylpyruvic acid Chemical compound OC(=O)C(=O)CC1=CC=CC=C1 BTNMPGBKDVTSJY-UHFFFAOYSA-N 0.000 description 1
- FMMOOAYVCKXGMF-UHFFFAOYSA-N linoleic acid ethyl ester Natural products CCCCCC=CCC=CCCCCCCCC(=O)OCC FMMOOAYVCKXGMF-UHFFFAOYSA-N 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- YLHXLHGIAMFFBU-UHFFFAOYSA-N methyl phenylglyoxalate Chemical compound COC(=O)C(=O)C1=CC=CC=C1 YLHXLHGIAMFFBU-UHFFFAOYSA-N 0.000 description 1
- CWKLZLBVOJRSOM-UHFFFAOYSA-N methyl pyruvate Chemical compound COC(=O)C(C)=O CWKLZLBVOJRSOM-UHFFFAOYSA-N 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 229960002900 methylcellulose Drugs 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000010445 mica Substances 0.000 description 1
- 229910052618 mica group Inorganic materials 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 229910052901 montmorillonite Inorganic materials 0.000 description 1
- JSCQSBGXKRTPHZ-SYKZHUKTSA-N mucidin Chemical compound CO\C=C(\C(=O)OC)/C(/C)=C\C=C\C1=CC=CC=C1 JSCQSBGXKRTPHZ-SYKZHUKTSA-N 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- VIKVSUVYUVJHOA-UHFFFAOYSA-N octyl 3-phenylprop-2-enoate Chemical compound CCCCCCCCOC(=O)C=CC1=CC=CC=C1 VIKVSUVYUVJHOA-UHFFFAOYSA-N 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- ZQTHOIGMSJMBLM-BUJSFMDZSA-N pangamic acid Chemical compound CN(C)CC(=O)OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O ZQTHOIGMSJMBLM-BUJSFMDZSA-N 0.000 description 1
- 108700024047 pangamic acid Proteins 0.000 description 1
- SERHXTVXHNVDKA-UHFFFAOYSA-N pantolactone Chemical compound CC1(C)COC(=O)C1O SERHXTVXHNVDKA-UHFFFAOYSA-N 0.000 description 1
- 229940115458 pantolactone Drugs 0.000 description 1
- SIEVQTNTRMBCHO-UHFFFAOYSA-N pantolactone Natural products CC1(C)OC(=O)CC1O SIEVQTNTRMBCHO-UHFFFAOYSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- FAQJJMHZNSSFSM-UHFFFAOYSA-N phenylglyoxylic acid Chemical compound OC(=O)C(=O)C1=CC=CC=C1 FAQJJMHZNSSFSM-UHFFFAOYSA-N 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 150000004714 phosphonium salts Chemical class 0.000 description 1
- 235000002949 phytic acid Nutrition 0.000 description 1
- 229940068041 phytic acid Drugs 0.000 description 1
- 239000000467 phytic acid Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 229920000151 polyglycol Polymers 0.000 description 1
- 239000010695 polyglycol Substances 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
- ONQDVAFWWYYXHM-UHFFFAOYSA-M potassium lauryl sulfate Chemical compound [K+].CCCCCCCCCCCCOS([O-])(=O)=O ONQDVAFWWYYXHM-UHFFFAOYSA-M 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- ZPWFUIUNWDIYCJ-UHFFFAOYSA-N propan-2-yl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC(C)C ZPWFUIUNWDIYCJ-UHFFFAOYSA-N 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 239000008165 rice bran oil Substances 0.000 description 1
- 238000007788 roughening Methods 0.000 description 1
- 235000002020 sage Nutrition 0.000 description 1
- 229930192014 saikosaponin Natural products 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 229940043230 sarcosine Drugs 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 230000036548 skin texture Effects 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- BTURAGWYSMTVOW-UHFFFAOYSA-M sodium dodecanoate Chemical compound [Na+].CCCCCCCCCCCC([O-])=O BTURAGWYSMTVOW-UHFFFAOYSA-M 0.000 description 1
- 229940082004 sodium laurate Drugs 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 229940045870 sodium palmitate Drugs 0.000 description 1
- GGXKEBACDBNFAF-UHFFFAOYSA-M sodium;hexadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCC([O-])=O GGXKEBACDBNFAF-UHFFFAOYSA-M 0.000 description 1
- 230000003381 solubilizing effect Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 229940035044 sorbitan monolaurate Drugs 0.000 description 1
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 1
- 235000019337 sorbitan trioleate Nutrition 0.000 description 1
- 229960000391 sorbitan trioleate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- ODBLHEXUDAPZAU-UHFFFAOYSA-N threo-D-isocitric acid Natural products OC(=O)C(O)C(C(O)=O)CC(O)=O ODBLHEXUDAPZAU-UHFFFAOYSA-N 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000011912 vitamin B7 Nutrition 0.000 description 1
- 239000011735 vitamin B7 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
- 235000007680 β-tocopherol Nutrition 0.000 description 1
- 239000011590 β-tocopherol Substances 0.000 description 1
- QUEDXNHFTDJVIY-DQCZWYHMSA-N γ-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-DQCZWYHMSA-N 0.000 description 1
- 239000002478 γ-tocopherol Substances 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は皮膚外用剤に関す
る。さらに詳しくは、優れた角質除去効果と肌荒れ改善
防止効果を有する皮膚外用剤に関する。The present invention relates to an external preparation for skin. More specifically, the present invention relates to an external preparation for skin having an excellent exfoliating effect and an effect of preventing and improving skin roughness.
【0002】[0002]
【従来の技術】化粧品等の皮膚外用剤の大きな目的の1
つは美肌状態の維持である。美肌状態を保つためには、
乾燥などにより重層化した角質を除去して表皮細胞のタ
ーンオーバーをスムーズにすることが重要であり、この
ため、角質除去剤を配合した皮膚外用剤が知られてい
る。BACKGROUND OF THE INVENTION One of the major purposes of skin external preparations such as cosmetics
One is to maintain a beautiful skin condition. To maintain beautiful skin condition,
It is important to remove the stratum corneum layered by drying or the like to make the turnover of epidermal cells smooth, and for this reason, external preparations for the skin containing a exfoliating agent are known.
【0003】[0003]
【発明が解決しようとする課題】本発明者等は、角質除
去剤を配合した皮膚外用剤について鋭意研究した結果、
特定の角質除去剤と特定の高分子シリコーンを組合せて
皮膚外用剤に配合すると、角質除去剤を単独に配合する
よりも角質除去効果が増大し、さらに、肌荒れ改善防止
効果、保湿効果も有する皮膚外用剤が得られるという新
たな知見を見出し本発明を完成するに至った。DISCLOSURE OF THE INVENTION The present inventors have conducted intensive studies on a skin external preparation containing a keratin removing agent,
When a specific exfoliating agent and a specific high-molecular silicone are combined into a skin external preparation, the exfoliating effect is increased as compared with the case where the exfoliating agent is blended alone, and further, a skin roughening preventing effect and a moisturizing effect. The present inventors have found a new finding that an external preparation can be obtained, and have completed the present invention.
【0004】本発明は、優れた角質除去効果、肌荒れ改
善防止効果及び保湿効果を有する皮膚外用剤を提供する
ことを目的とする。An object of the present invention is to provide an external preparation for skin having an excellent exfoliating effect, an effect of preventing and improving skin roughness, and a moisturizing effect.
【0005】[0005]
【課題を解決するための手段】すなわち、本発明は、下
記一般式「化2」で表わされる高分子シリコーンの一種
または二種以上と、低分子ベタイン、ヒドロキシカルボ
ン酸若しくはそのエステル、ラクトンまたは塩、ケトカ
ルボン酸若しくはそのエステル、ラクトンまたは塩から
なる群から選ばれた角質除去剤の一種または二種以上と
を含有することを特徴とする皮膚外用剤を提供するもの
である。That is, the present invention relates to a polymer silicone represented by the following general formula (1) or a combination thereof and a low molecular weight betaine, hydroxycarboxylic acid or its ester, lactone or salt. An external preparation for skin characterized by containing one or more exfoliants selected from the group consisting of ketocarboxylic acid or its ester, lactone or salt.
【化2】 (R1はメチル基または一部がフェニル基を表し、R2は
メチル基または水酸基を表す。また、nは、3000〜
20000の整数を表す。)Embedded image (R 1 represents a methyl group or a part thereof represents a phenyl group, R 2 represents a methyl group or a hydroxyl group.
Represents an integer of 20,000. )
【0006】また、本発明は、上記角質除去剤がトリメ
チルグリシンであることを特徴とする上記の皮膚外用剤
を提供するものである。The present invention also provides the above external preparation for skin, wherein the exfoliating agent is trimethylglycine.
【0007】以下、本発明について詳述する。本発明に
おいて用いる高分子シリコーンとは、上記化学式「化
2」で表される重合度が3、000〜20、000の高
分子シリコーンであり、常温で軟質ゴム状の性状を呈す
るものである。具体例で示すと、ジメチルポリシロキサ
ン、メチルフェニルポリシロキサン、末端水酸基含有メ
チルフェニルポリシロキサン等を使用出来る。Hereinafter, the present invention will be described in detail. The polymeric silicone used in the present invention is a polymeric silicone represented by the above chemical formula (Chemical Formula 2) and having a degree of polymerization of 3,000 to 20,000, and exhibits a soft rubber-like property at room temperature. As specific examples, dimethylpolysiloxane, methylphenylpolysiloxane, methylphenylpolysiloxane having a terminal hydroxyl group, and the like can be used.
【0008】高分子シリコーンの配合量は皮膚外用剤全
量に対して、好ましくは0.001〜5重量%、さらに
好ましくは0.01〜3重量%である。[0008] The amount of the high molecular silicone is preferably 0.001 to 5% by weight, more preferably 0.01 to 3% by weight, based on the total amount of the external preparation for skin.
【0009】本発明においては、各種の角質除去剤の中
で、特に、低分子ベタイン、ヒドロキシカルボン酸若し
くはそのエステル、ラクトンまたは塩、ケトカルボン酸
若しくはそのエステル、ラクトンまたは塩と、上記高分
子シリコーンとを併用すると、角質除去効果が増大する
と同時に優れた肌荒れ改善防止効果及び保湿効果も有す
る皮膚外用剤が得られるものである。In the present invention, among the various exfoliants, in particular, low molecular weight betaine, hydroxycarboxylic acid or its ester, lactone or salt, ketocarboxylic acid or its ester, lactone or salt, and the above-mentioned high molecular silicone and When used in combination, an external preparation for the skin can be obtained which has an excellent effect of removing skin exfoliation and also has an excellent effect of preventing and improving skin roughness and a moisturizing effect.
【0010】角質除去剤の低分子ベタインとは、分子量
100〜200のベタイン類を意味し、第4アンモニウ
ム塩、スルホニウム塩、ホスホニウム塩などの分子内塩
で両性イオンを形成するものを包含し得る。分子量を2
00以下の低分子ベタインとする理由は、分子量が20
0を越えるベタインは界面活性剤としての性質を帯び、
皮膚を荒らす傾向があるからである。本発明において
は、下記化学式「化3」で表される低分子ベタインが好
ましく使用される。[0010] The low molecular weight betaine of the exfoliating agent means betaines having a molecular weight of 100 to 200, and may include those which form zwitterions with internal salts such as quaternary ammonium salts, sulfonium salts and phosphonium salts. . 2 molecular weight
The reason for using low-molecular-weight betaine having a molecular weight of 20 or less is that
Betaine exceeding 0 takes on the properties of a surfactant,
This is because it tends to roughen the skin. In the present invention, low molecular betaine represented by the following chemical formula (Formula 3) is preferably used.
【化3】 [R1、R2及びR3は、それぞれ独立に炭素原子数が1
〜6の直鎖又は分岐鎖のアルキル基を表し、nは0また
は正の整数を表す。但し、R1、R2及びR3の炭素原子
数の和とnとの総和が8以下である。] R1、R2及びR3の具体例としては、メチル基、エチル
基、プロピル基、イソプロピル基、ブチル基、イソブチ
ル基、sec−ブチル基、tert−ブチル基、ヘキシ
ル基、イソヘキシル基、3−メチルペンチル基、2,2
−ジメチルブチル基、2,3−ジメチルブチル基等が例
示される。これらのR1、R2及びR3は、それぞれ同一
であっても異なっていてもよい。本発明においては、上
記化学式「化3」において、R1、R2及びR3がすべて
メチル基でnが0であるトリメチルグリシンが最も好適
に使用される。また、R1、R2及びR3がすべてメチル
基でnが2であるγ−ブチロベタインも好適に使用され
る。Embedded image [R 1 , R 2 and R 3 each independently have 1 carbon atom
Represents a linear or branched alkyl group of from 6 to 6, and n represents 0 or a positive integer. However, the total sum of the number of carbon atoms of R 1 , R 2 and R 3 and n is 8 or less. Specific examples of R 1 , R 2 and R 3 include methyl, ethyl, propyl, isopropyl, butyl, isobutyl, sec-butyl, tert-butyl, hexyl, isohexyl, -Methylpentyl group, 2,2
-Dimethylbutyl group, 2,3-dimethylbutyl group and the like. These R 1 , R 2 and R 3 may be the same or different. In the present invention, trimethylglycine in which R 1 , R 2, and R 3 are all methyl groups and n is 0 in the chemical formula (3) is most preferably used. Further, γ-butyrobetaine in which all of R 1 , R 2 and R 3 are methyl groups and n is 2 is also preferably used.
【0011】本発明においては、低分子ベタインを用い
ると、角質除去効果の増大の他に、さらにムコ多糖類等
の保湿剤を配合した場合にそのべたつきを抑えるという
効果を発揮し、優れた保湿効果、肌荒れ改善防止効果も
発揮するので、トリメチルグリシン等の低分子ベタイン
を用いることが好ましい。In the present invention, when low molecular weight betaine is used, an effect of suppressing stickiness when a humectant such as mucopolysaccharide is added is exhibited, in addition to an increase in the exfoliating effect. It is preferable to use a low-molecular-weight betaine such as trimethylglycine since it also exerts an effect and an effect of preventing and improving skin roughness.
【0012】角質除去剤のヒドロキシカルボン酸若しく
はそのエステル、ラクトンまたは塩、又は、ケトカルボ
ン酸若しくはそのエステル、ラクトンまたは塩は、具体
例として、例えば、グリコール酸、ベンジル酸、トロバ
酸、乳酸、リンゴ酸、クエン酸、イソクエン酸、シトラ
マル酸、タルトロン酸、酒石酸、グルコン酸、ガラクト
ン酸、アルファーヒドロキシイソ酪酸、フェニル乳酸、
マルデン酸、アトロラクチン酸、グルコノラクトン、ガ
ラクトノラクトン、リボン酸、リボノラクトン、パント
イン酸、パントラクトン、パントテイン酸、アルファー
ヒドロキシ酪酸、ベータヒドロキシ酪酸、キナ酸ピルビ
ン酸、フェニルピルビン酸、ピルビン酸メチル、ピルビ
ン酸エチル、アスコルビン酸、ベンゾイルギ酸、ベンゾ
イルギ酸メチル、ベンゾイルギ酸エチル等が挙げられ
る。特に好ましくは、グリコール酸、乳酸、リンゴ酸及
びクエン酸である。Examples of the exfoliating agent, hydroxycarboxylic acid or its ester, lactone or salt, or ketocarboxylic acid or its ester, lactone or salt include, for example, glycolic acid, benzylic acid, toroic acid, lactic acid, malic acid , Citric acid, isocitric acid, citramalic acid, tartronic acid, tartaric acid, gluconic acid, galactonic acid, alpha-hydroxyisobutyric acid, phenyl lactic acid,
Maldenic acid, atrolactic acid, gluconolactone, galactonolactone, ribbon acid, ribonolactone, pantoic acid, pantolactone, pantothenic acid, alpha-hydroxybutyric acid, beta-hydroxybutyric acid, pyruvate quinate, phenylpyruvate, methyl pyruvate, Examples include ethyl pyruvate, ascorbic acid, benzoyl formate, methyl benzoyl formate, and ethyl benzoyl formate. Particularly preferred are glycolic acid, lactic acid, malic acid and citric acid.
【0013】本発明に用いる角質除去剤は、上記の角質
除去剤を単独または2種以上を任意に組合せて使用する
ことが出来る。角質除去剤の配合量は、皮膚外用剤全量
に対して好ましくは0.01〜30重量%、さらに好ま
しくは0.01〜20重量%である。0.01%未満で
は本発明の効果が十分に発揮されず、30重量%を越え
て配合しても配合量の増加に見合った効果の増大は期待
できない場合がある。As the exfoliants used in the present invention, the above exfoliants may be used alone or in any combination of two or more. The amount of the exfoliating agent is preferably 0.01 to 30% by weight, more preferably 0.01 to 20% by weight, based on the total amount of the external preparation for skin. If the amount is less than 0.01%, the effect of the present invention cannot be sufficiently exhibited, and even if the amount exceeds 30% by weight, an increase in the effect corresponding to the increase in the amount may not be expected.
【0014】本発明の皮膚外用剤とは、化粧料、医薬
品、医薬部外品等として、外皮に適用されるものを指
し、従って、その剤形も、水溶液系、可溶化系、乳化
系、粉末系、油液系、ゲル系、軟膏系、水−油2層系、
水−油−粉末3層系等、幅広い形態を採ることが出来
る。The external preparation for skin of the present invention refers to those applied to the outer skin as cosmetics, pharmaceuticals, quasi-drugs, etc., and accordingly, the dosage form is also an aqueous solution type, a solubilizing type, an emulsifying type, Powder system, oil-liquid system, gel system, ointment system, water-oil two-layer system,
It can take a wide range of forms such as a three-layer water-oil-powder system.
【0015】本発明の皮膚外用剤には、上記必須成分の
ほかに、通常、化粧料や医薬品等の皮膚外用剤に用いら
れる他の成分、例えば、二酸化チタン、マイカ、タルク
等の粉末成分、月見草油、アボガド油、ミンク油、ホホ
バ油、マカデミアナッツ油、トウモロコシ油、ナタネ
油、ヒマシ油、ヒマワリ油、カカオ油、ヤシ油、コメヌ
カ油、オリーブ油、ラノリン、スクワレン等の天然動植
物油脂類、流動パラフィン、スクワラン、ワセリン等の
炭化水素類、パラフィンワックス、鯨ロウ、ミツロウ、
キャンデリラワックス、カルナウバロウ等のワックス
類、セタノール、ステアリルアルコール等の高級アルコ
ール類、ミリスチン酸、パルミチン酸、ステアリン酸、
ベヘニン酸、イソステアリン酸、オレイン酸、リノレン
酸、リノール酸、オキシステアリン酸等の高級脂肪酸
類、ミリスチン酸イソプロピル、パルミチン酸イソプロ
ピル、ステアリン酸イソプロピル、2エチルヘキサン酸
グリセロール、トリ2−エチルヘキサン酸グリセリル、
テトラ2−エチルヘキサン酸ペンタエリスリット等の脂
肪酸エステル類、ジエチレングリコールモノプロピルエ
ーテル、ポリオキシエチレンポリオキシプロピレンペン
タエリスリトールエーテル、ポリオキシプロピレンブチ
ルエーテル、リノール酸エチル等の極性オイル、シリコ
ーン油、パラアミノ安息香酸、ホモメチル−7N−アセ
チルアラントイラニレート、ブチルメトキシベンゾイル
メタン、ジ−パラメトキシケイヒ酸−モノ−2−エチル
ヘキサン酸グリセリル、アミルサリシレート、オクチル
シンナメート、2、4−ジヒドロキシベンゾフェノン等
の紫外線吸収剤、ポリエチレングリコール、ソルビトー
ル、キシレトール、マルチトール等の保湿剤、メチルセ
ルロース、アラビアガム、ポリビニルアルコール、モン
モリロナイト、ラポナイト等の増粘剤、エタノール、
1、3−ブチレングリコール等の有機溶剤、ブチルヒド
ロキシトルエン、トコフェロール、フィチン酸等の酸化
防止剤、安息香酸、サリチル酸、ソルビン酸、パラオキ
シ安息香酸アルキルエステル(エチルパラベン、ブチル
パラベン等)、ヘキサクロロフェン等の抗菌防腐剤、ア
シルサルコシン酸例えばラウロイルコシンナトリウ
ム)、グルタチオン、クエン酸、リンゴ酸、酒石酸、乳
酸等の有機酸、ビタミンAおよびその誘導体、ビタミン
B6 塩酸塩、ビタミンB6 トリパルミテート、ビタ
ミンB6 ジオクタノエート、ビタミンB2 及びその
誘導体、ビタミンB12、ビタミンB15及びその誘導
体等のビタミンB類、アスコルビン酸、アスコルビン酸
硫酸エステル(塩)、アスコルビン酸リン酸エステル
(塩)、アスコルビン酸ジパルミテート等のビタミンC
類、α−トコフェロール、β−トコフェロール、γ−ト
コフェロール、ビタミンE−アセテ−ト、ビタミンE−
ニコチネート等のビタミンE類、ビタミンD類、ビタミ
ンH、パントテン酸、パントテチン等のビタミン類、ニ
コチン酸アミド、ニコチン酸ベンジル、γ−オリザノー
ル、アラントイン、グリチルリチン酸(塩)、グリチル
レチン酸およびその誘導体、ヒノキチオール、ムシジ
ン、ビサボロール、ユーカリプトール、チモールイノシ
トール、サポニン類(サイコサポニン、ニンジンサポニ
ン、ヘチマサポニン、ムクロジサポニン等)、パントテ
ルエチルエーテル、エチニルエストラジオール、セファ
ランジン、プラセンタエキス等の各種薬剤、ギシギシ、
クララ、コウホネ、オレンジ、セージ、ノコギリ草、ゼ
ニアオイ、センキュウ、センブリ、タイム、トウキ、ト
ウヒ、バーチ、スギナ、ヘチマ、マロニエ、ユキノシ
タ、アルニカ、ユリ、ヨモギ、シャクヤク、アロエ、ク
チナシ、サワラ等を、有機溶媒、アルコール、多価アル
コール、水、水性アルコール等で抽出した天然エキス、
色素、モノラウリン酸ソルビタン、セスキオレイン酸ソ
ルビタン、トリオレイン酸ソルビタン、モノラウリン酸
ポリオキシエチレンソルビタン、ポリエチレングリコー
ルモノオレート、ポリオキシエチレンアルキルエーテ
ル、ポリグリコールジエステル、ラウロイルジエタノー
ルアマイド、脂肪酸イソプロパノールアマイド、マルチ
トールヒドロキシ脂肪族エーテル、アルキル化多糖、ア
ルキルグルコシド、シュガーエステル等の非イオン界面
活性剤、ステアリルトリメチルアンモニウムクロライ
ド、塩化ベンザルコニウム、ラウリルアミンオキサイド
等のカチオン界面活性剤、パルミチン酸ナトリウム、ラ
ウリン酸ナトリウム、ラウリル硫酸カリウム、アルキル
硫酸トリエタノールアミンエーテル、ロート油、リニア
ドデシルベンゼン硫酸、ポリオキシエチレン硬化ヒマシ
油マイレン酸、アシルメチルタウリン等のアニオン界面
活性剤、香料、精製水等の任意の成分を配合して常法に
より製造することが可能である。The external preparation for skin of the present invention includes, in addition to the above essential components, other components usually used in external preparations for skin such as cosmetics and pharmaceuticals, for example, powder components such as titanium dioxide, mica, and talc; Natural animal and vegetable oils and fats such as evening primrose oil, avocado oil, mink oil, jojoba oil, macadamia nut oil, corn oil, rapeseed oil, castor oil, sunflower oil, cocoa oil, coconut oil, rice bran oil, olive oil, lanolin, squalene, and liquid paraffin , Squalane, petrolatum and other hydrocarbons, paraffin wax, whale wax, beeswax,
Waxes such as candelilla wax, carnauba wax, higher alcohols such as cetanol and stearyl alcohol, myristic acid, palmitic acid, stearic acid,
Higher fatty acids such as behenic acid, isostearic acid, oleic acid, linolenic acid, linoleic acid, oxystearic acid, isopropyl myristate, isopropyl palmitate, isopropyl stearate, glycerol 2-ethylhexanoate, glyceryl tri-2-ethylhexanoate,
Fatty acid esters such as tetra-2-ethylhexanoic acid pentaerythritol, diethylene glycol monopropyl ether, polyoxyethylene polyoxypropylene pentaerythritol ether, polyoxypropylene butyl ether, polar oils such as ethyl linoleate, silicone oil, para-aminobenzoic acid, UV absorbers such as homomethyl-7N-acetylallantranilate, butylmethoxybenzoylmethane, di-paramethoxycinnamic acid-glyceryl mono-2-ethylhexanoate, amyl salicylate, octylcinnamate and 2,4-dihydroxybenzophenone; Moisturizers such as polyethylene glycol, sorbitol, xylitol, maltitol, methylcellulose, gum arabic, polyvinyl alcohol, montmorillonite, Thickening of the night, such as, ethanol,
Organic solvents such as 1,3-butylene glycol, antioxidants such as butylhydroxytoluene, tocopherol, and phytic acid, benzoic acid, salicylic acid, sorbic acid, alkyl esters of para-hydroxybenzoic acid (ethylparaben, butylparaben, etc.), hexachlorophene, etc. Antibacterial preservatives, acyl sarcosine (e.g. sodium lauroylcosine), organic acids such as glutathione, citric acid, malic acid, tartaric acid, lactic acid, vitamin A and its derivatives, vitamin B6 hydrochloride, vitamin B6 tripalmitate, vitamin B6 dioctanoate , Vitamin B2 and its derivatives, vitamin B12 such as vitamin B12, vitamin B15 and its derivatives, ascorbic acid, ascorbic acid sulfate (salt), ascorbic acid phosphate (salt), dipal ascorbic acid Vitamin C such as mitates
, Α-tocopherol, β-tocopherol, γ-tocopherol, vitamin E-acetate, vitamin E-
Vitamin E such as nicotinate, vitamin D, vitamin H, pantothenic acid, vitamins such as pantothetin, nicotinamide, benzyl nicotinate, γ-oryzanol, allantoin, glycyrrhizic acid (salt), glycyrrhetinic acid and derivatives thereof, hinokitiol , Mucidin, bisabolol, eucalyptol, thymol inositol, saponins (saikosaponin, carrot saponin, leptimasaponin, muclodisaponin, etc.), various drugs such as pantoterethyl ether, ethinyl estradiol, cephalandin, placenta extract, etc.,
Clara, sorghum, orange, sage, saw, grass, mallow, spruce, birch, sugi, luffa, marronnier, yukinoshita, arnica, lily, mugwort, peonies, aloe, gardenia, sawara, etc. Natural extracts extracted with solvents, alcohols, polyhydric alcohols, water, aqueous alcohols, etc.
Pigments, sorbitan monolaurate, sorbitan sesquioleate, sorbitan trioleate, polyoxyethylene sorbitan monolaurate, polyethylene glycol monooleate, polyoxyethylene alkyl ether, polyglycol diester, lauroyl diethanol amide, fatty acid isopropanol amide, maltitol hydroxy fat Surfactants such as aliphatic ethers, alkylated polysaccharides, alkyl glucosides, and sugar esters; cationic surfactants such as stearyltrimethylammonium chloride, benzalkonium chloride and laurylamine oxide; sodium palmitate, sodium laurate, and lauryl sulfate Potassium, alkyl sulfate triethanolamine ether, funnel oil, linear dodecylbenzene sulfate Polyoxyethylene hardened castor oil maleic acid, anionic surfactants such as acyl methyl taurine, perfumes, may be manufactured in a conventional manner by blending the optional components such as purified water.
【0016】[0016]
【実施例】次に、本発明を実施例および比較例によりさ
らに詳細に説明する。本発明はこれらの実施例に限定さ
れるものではない。なお、実施例及び比較例での配合量
は全て重量%を意味する。Next, the present invention will be described in more detail with reference to Examples and Comparative Examples. The present invention is not limited to these examples. In addition, the compounding amount in an Example and a comparative example all means a weight%.
【0017】皮膚外用剤として、「表1」及び「表2」
に示す処方で実施例及び比較例の美容液、「表3」に示
す処方で実施例及び比較例の乳液を製造し、その効果を
以下の試験法、評価法により判定した。As a skin external preparation, "Table 1" and "Table 2"
And the emulsions of the examples and the comparative examples were prepared according to the formulations shown in Table 3 and the effects thereof were determined by the following test methods and evaluation methods.
【0018】「角質除去効果」皮膚表面の古い角質の量
は、ファイバー式光源付きビデオマイクロスコープを用
いて皮膚表面を100倍に拡大して撮影し、映像を画像
処理装置に入力して、角質層のスケーリングを起こして
いる部分(白く光っている部分)の面積比を2値化処理
により%で求め、古い角質の量とした。角質除去効果試
験は健常人である女性専門パネル5名の額部を用いて行
った。実施例及び比較例の皮膚外用剤を塗布する前に、
皮膚表面の古い角質量を測定した。その後、実施例及び
比較例の皮膚外用剤を0.5gを塗布し、約1時間後に
同一部位での古い角質量を測定した。洗浄前の古い角質
量と洗浄後の古い角質量から、角質除去率(%)を求め
た。"Effect of exfoliation" The amount of old exfoliation on the skin surface can be measured by using a video microscope equipped with a fiber light source to magnify and photograph the skin surface by 100 times, inputting an image to an image processing apparatus, The area ratio of the portion where the layer was scaling (the portion that glows white) was determined in% by the binarization process, and was determined as the amount of old keratin. The exfoliating effect test was performed using the foreheads of five healthy female professional panels. Before applying the skin external preparations of Examples and Comparative Examples,
The old angular mass of the skin surface was measured. Thereafter, 0.5 g of the skin external preparations of Examples and Comparative Examples were applied, and about 1 hour later, the old angular mass at the same site was measured. From the old horn mass before washing and the old horn mass after washing, the exfoliating rate (%) was determined.
【数1】 A0:洗浄前の古い角質量 A1:洗浄後の古い角質量 [評価基準] ◎:角質除去力優良 角質除去率80%以上 ○:角質除去力良好 角質除去率60%以上 △:角質除去力普通 角質除去率30%以上 ×:角質除去力不良 角質除去率30%未満(Equation 1) A0: Old horn mass before washing A1: Old horn mass after washing [Evaluation criteria] :: Excellent exfoliating power 80% or more ○: Good exfoliating power 60% or more △: Normal exfoliating power Exfoliating rate of 30% or more ×: Poor exfoliating power Exfoliating rate of less than 30%
【0019】「肌荒れ改善防止効果」女性専門パネル1
0人の前腕の何箇所かに、活性剤(ラウリル硫酸ナトリ
ウム水溶液)10%水溶液を3日間塗布して故意に肌荒れ
をおこした。その後、実施例及び比較例の皮膚外用剤を
1日2回し塗布し、塗布開始5日後にレプリカ法および
スキンコンダクタンスによって肌表面の状態を測定し、
肌荒れ後何も塗布しない部位と比較して肌荒れ改善防止
効果を判定し評価した。 [判定基準] 著効:肌荒れの症状が消失した 有効:肌荒れの症状が弱くなった やや有効:肌荒れの症状がやや弱くなった 無効:肌荒れの症状に変化が認められない なお、ここでの肌荒れの症状とは、次のいずれかの症状
を意味する。 (1)角質層剥離、紅斑がおきる。 (2)皮溝、皮丘がはっきりせず、肌のキメがそろわな
い。 [評価基準] ◎:女性専門パネルが、著効、有効、およびやや有効を
示す割合が80%以上 ○:女性専門パネルが、著効、有効、およびやや有効を
示す割合が50%以上〜80未満 △:女性専門パネルが、著効、有効、およびやや有効を
示す割合が30%以上〜50未満 ×:女性専門パネルが、著効、有効、およびやや有効を
示す割合が30%未満"Effect of improving skin roughness" Panel 1 for women
A 10% aqueous solution of an activator (sodium lauryl sulfate aqueous solution) was applied to some of the forearms of 0 persons for 3 days, and the skin was intentionally roughened. Thereafter, the skin external preparations of Examples and Comparative Examples were applied twice a day, and 5 days after the start of application, the condition of the skin surface was measured by a replica method and skin conductance,
The effect of preventing and improving skin roughness was determined and evaluated in comparison with a site where nothing was applied after skin roughness. [Judgment criteria] Significant effect: The symptoms of rough skin disappeared Effective: The symptoms of rough skin weakened Slightly effective: The symptoms of rough skin became slightly weaker Invalid: No change was observed in the symptoms of rough skin The rough skin here Means any of the following symptoms. (1) Exfoliation of the stratum corneum and erythema occur. (2) The skin sulcus and skin hills are not clear, and the skin texture is not uniform. [Evaluation Criteria] :: 80% or more of female professional panels show significant, effective, and somewhat effective ○: 50% or more of female professional panels exhibit significant, effective, and somewhat effective Less than Δ: The percentage of female professional panels showing significant, effective, and somewhat effective is 30% or more and less than 50 ×: The percentage of female professional panels showing significant, effective, and somewhat effective is less than 30%
【0020】「保湿効果」保湿効果は、水分蒸発速度の
測定により評価した。2.0X2.0cmの濾紙上に10μlの実施
例及び比較例の皮膚外用剤を滴下後、1分ごとにその重
量減少を10分間測定し、1分当たりに減少する重量を
求めた。 [評価基準] ◎:水分蒸発速度 0.50μg/min. 以下 ○:水分蒸発速度 0.50〜0.55μg/min. △:水分蒸発速度 0.55〜0.60μg/min. ×:水分蒸発速度 0.60μg/min. 以上"Moisturizing effect" The moisturizing effect was evaluated by measuring the water evaporation rate. After dropping 10 μl of the skin external preparations of Examples and Comparative Examples onto a 2.0 × 2.0 cm filter paper, the weight loss was measured every minute for 10 minutes, and the weight loss per minute was determined. [Evaluation criteria] ◎: Water evaporation rate 0.50 μg / min or less ○: Water evaporation rate 0.50 to 0.55 μg / min. △: Water evaporation rate 0.55 to 0.60 μg / min. ×: Water evaporation rate 0.60 μg / min.
【0021】「実使用効果」健常人女性専門パネル5名
で実施例及び比較例の皮膚外用剤を1日1回2週間連用
し、官能評価により連用前後の皮膚の感触の違いを次の
ようにスコアをつけ、スコア平均から次のように評価し
た。 「スコア」 2:皮膚のざらつきがなくなり、つるつるした感触にな
った。 1:やや皮膚のざらつきがなくなった。 0:皮膚のざらつきがなくならない。 [評価基準] ○:スコア平均1.0以上 △:スコア平均0.5以上 ×:スコア平均0.5未満[Effects of actual use] The skin external preparations of Examples and Comparative Examples were continuously used once a day for two weeks by five healthy female professional panels, and the difference in the feel of the skin before and after continuous use was determined by sensory evaluation as follows. Was given a score, and the average score was evaluated as follows. “Score” 2: Skin roughness disappeared, giving a slippery feel. 1: The roughness of the skin was slightly reduced. 0: Skin roughness does not disappear. [Evaluation Criteria] ○: Score average 1.0 or more △: Score average 0.5 or more ×: Score average less than 0.5
【0022】[0022]
【表1】 ----------------------------------------------------------------------- 実施例 比較例 1 2 3 1 2 3 ----------------------------------------------------------------------- エタノ−ル 5.0 5.0 5.0 5.0 5.0 5.0 カルボキシビニルポリマー 0.3 0.3 0.3 0.3 0.3 0.3 ポリオキシエチレン オレイルエーテル(15モル) 0.8 0.8 0.8 0.8 0.8 0.8 メチルパラベン 0.1 0.1 0.1 0.1 0.1 0.1 高分子シリコ−ン 0.1 0.1 0.1 0.1 --- --- クエン酸 5.0 --- 5.0 --- 5.0 --- トリメチルグリシン --- 5.0 5.0 --- --- 5.0 精製水 残部 残部 残部 残部 残部 残部 ----------------------------------------------------------------------- 角質除去効果 ◎ ◎ ◎ × ○ ○ 肌荒れ改善防止効果 ○ ◎ ◎ △ △ △ 保湿効果 ○ ◎ ◎ × × ○ 実使用効果 ○ ○ ○ × △ △ ----------------------------------------------------------------------- (製法)エタノールの一部にポリオキシエチレンオレイ
ルエーテルおよびアミノ変性シリコーンとメチルパラベ
ンを溶解する。別に精製水とエタノールの残部にカルボ
キシビニルポリマー、トリメチルグリシン又はクエン酸
を溶解する。エタノール相を水相中に添加、可溶化して
美容液を得た。なお、高分子シリコーンは、前記化学式
「化2」でR1及びR2がメチル基でnが6000、粘性
20csの高分子量ジメチルポリシロキサンを用いた。[Table 1] ---------------------------------------------- ------------------------- Example Comparative example 1 2 3 1 2 3 --------------- -------------------------------------------------- ------ Ethanol 5.0 5.0 5.0 5.0 5.0 5.0 Carboxyvinyl polymer 0.3 0.3 0.3 0.3 0.3 0.3 Polyoxyethylene oleyl ether (15 mol) 0.8 0.8 0.8 0.8 0.8 0.8 Methyl paraben 0.1 0.1 0.1 0.1 0.1 0.1 Polymer silicone 0.1 0.1 0.1 0.1 --- --- Citric acid 5.0 --- 5.0 --- 5.0 --- Trimethylglycine --- 5.0 5.0 --- --- 5.0 Purified water Remaining Remaining Remaining Remaining Remaining --- -------------------------------------------------- ------------------ Exfoliating effect ◎ ◎ ◎ × ○ ○ Skin roughness improvement prevention effect ○ ◎ ◎ △ △ △ Moisturizing effect ○ ◎ ◎ × × ○ Actual use effect ○ ○ ○ × △ △ --------------------------------------------------- ------------------------- (Production method) Polyoxyethylene Dissolving the alkylene oleyl ether and amino-modified silicone and methyl paraben. Separately, carboxyvinyl polymer, trimethylglycine or citric acid is dissolved in purified water and the remainder of ethanol. The ethanol phase was added to the aqueous phase and solubilized to obtain a serum. As the high-molecular silicone, high-molecular-weight dimethylpolysiloxane having a viscosity of 20 cs with R 1 and R 2 being methyl groups, n being 6000 and having a chemical formula of Chemical Formula 2 was used.
【0023】[0023]
【表2】ーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーー 実施例 比較例 4 5 6 4 5 6ーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーー エタノ−ル 5.0 5.0 5.0 5.0 5.0 5.0 カルボキシビニルポリマー 0.3 0.3 0.3 0.3 0.3 0.3 ポリオキシエチレン オレイルエーテル(15モル) 0.8 0.8 0.8 0.8 0.8 0.8 メチルパラベン 0.1 0.1 0.1 0.1 0.1 0.1 高分子シリコ−ン 0.1 0.1 0.1 --- --- --- 乳酸 5.0 --- --- 5.0 --- --- リンゴ酸 --- 5.0 --- --- 5.0 --- グリコール酸 --- --- 5.0 --- --- 5.0 精製水 残部 残部 残部 残部 残部 残部ーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーー 角質除去効果 ◎ ◎ ◎ ○ ○ ○ 肌荒れ改善防止効果 ○ ○ ○ △ △ △ 保湿効果 ○ ○ ○ × × × 実使用効果 ○ ○ ○ △ △ △ーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーーー (製法)実施例1と同様にして美容液を得た。なお、高
分子シリコーンは、前記化学式「化2」でR1及びR2が
メチル基でnが6000、粘性20csの高分子量ジメ
チルポリシロキサンを用いた。[Table 2]-----------------------------------------------------] Example Comparative Example 4 5 6 4 5 6------------------------------------------------------------------------------------------------------------------------------ ----------------------------------------------------------------- -------Ethanol 5.0 5.0 5.0 5.0 5.0 5.0 Carboxyvinyl polymer 0.3 0.3 0.3 0.3 0.3 0.3 Polyoxyethylene oleyl ether (15 mol) 0.8 0.8 0.8 0.8 0.8 0.8 Methyl paraben 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 --- --- --- Lactic acid 5.0 --- --- 5.0 --- --- Malic acid --- 5.0 --- --- 5.0 --- Glycolic acid ---- -5.0 --- --- 5.0 Purified water Remaining Remaining Remaining Remaining Remaining Remaining Remaining ー ー ー ー ーExfoliating exfoliating Effect ◎ ◎ ◎ ○ ○ ○ Skin roughness improvement prevention effect ○ ○ ○ △ △ △ Moisturizing effect ○ ○ ○ × × × Actual use effect ○ ○ ○ △ △ △ ー ー ー ー ー ー ー ー ー----------------------------------------------------------------- --- (Preparation method) A serum was obtained in the same manner as in Example 1. As the high-molecular silicone, high-molecular-weight dimethylpolysiloxane having a viscosity of 20 cs with R 1 and R 2 being methyl groups, n being 6000 and having a chemical formula of Chemical Formula 2 was used.
【0024】[0024]
【表3】 ----------------------------------------------------------------------- 実施例 比較例 7 8 9 7 8 9 ----------------------------------------------------------------------- 1 精製水 残部 残部 残部 残部 残部 残部 2 カルボキシルビニルポリマ− 0.2 0.2 0.2 0.2 0.2 0.2 3 アルキル変性カルボキシル ビニルポリマ− 0.7 0.7 0.7 0.7 0.7 0.7 4 KOH 0.3 0.3 0.3 0.3 0.3 0.3 5 スクワラン 10.0 10.0 10.0 10.0 10.0 10.0 6 ワセリン 2.0 2.0 2.0 2.0 2.0 2.0 7 セタノール 1.0 1.0 1.0 1.0 1.0 1.0 8 ラノリンアルコール 2.0 2.0 2.0 2.0 2.0 2.0 9 流動パラフィン 8.0 8.0 8.0 8.0 8.0 8.0 10トリメチルグリシン --- 5.0 5.0 ーーー 5.0 --- 11乳酸 5.0 --- 5.0 --- --- 5.0 12高分子シリコーン 5.0 5.0 5.0 5.0 --- --- 13防腐剤 0.2 0.2 0.2 0.2 0.2 0.2 14香料 0.05 0.05 0.05 0.05 0.05 0.05 ----------------------------------------------------------------------- 角質除去効果 ◎ ◎ ◎ × ○ ○ 肌荒れ改善防止効果 ◎ ◎ ◎ △ △ △ 保湿効果 ◎ ◎ ◎ ○ × ○ 実使用効果 ○ ◎ ◎ × △ △ ----------------------------------------------------------------------- (製法)(5)(6)(7)(8)(9)(12)(1
3)(14)の油分を均一に溶解させ、70℃に保つ。
別釜で(1)の一部に溶解させた(2)(3)と(1
0)または(11)の水相を均一に溶解させる。水相に
前記油相パーツを添加し、(1)の一部に溶解した
(4)を加えて乳液を得た。なお、高分子シリコーン
は、前記化学式「化2」でR1及びR2がメチル基でnが
6000、粘性20csの高分子量ジメチルポリシロキ
サンを用いた。[Table 3] ---------------------------------------------- ------------------------- Example Comparative Example 7 8 9 7 8 9 --------------- -------------------------------------------------- ------ 1 Purified water Remaining Remaining Remaining Remaining Remaining Remaining 2 Carboxyvinyl polymer 0.2 0.2 0.2 0.2 0.2 0.2 3 Alkyl-modified carboxylvinyl polymer 0.7 0.7 0.7 0.7 0.7 0.7 4 KOH 0.3 0.3 0.3 0.3 0.3 0.3 5 Squalane 10.0 10.0 10.0 10.0 10.0 10.0 6 Vaseline 2.0 2.0 2.0 2.0 2.0 2.0 7 Cetanol 1.0 1.0 1.0 1.0 1.0 1.0 8 Lanolin alcohol 2.0 2.0 2.0 2.0 2.0 2.0 9 Liquid paraffin 8.0 8.0 8.0 8.0 8.0 8.0 10 Trimethylglycine --- 5.0 5.0 ー ー 5.0- -11 Lactic acid 5.0 --- 5.0 --- --- 5.0 12 High molecular silicone 5.0 5.0 5.0 5.0 --- --- 13 Preservative 0.2 0.2 0.2 0.2 0.2 0.2 14 Fragrance 0.05 0.05 0.05 0.05 0.05 0.05 ---- -------------------------------------------------- ----------------- Exfoliating effect ◎ ◎ ◎ × ○ Skin roughness improvement prevention effect ◎ ◎ ◎ △ △ △ Moisturizing effect ◎ ◎ ◎ ○ × ○ Actual use effect ○ ◎ ◎ × △ △ ---------------------- ------------------------------------------------- ( Production method) (5) (6) (7) (8) (9) (12) (1)
3) The oil of (14) is uniformly dissolved and kept at 70 ° C.
(2) (3) and (1) dissolved in a part of (1) in separate pots
The aqueous phase of (0) or (11) is uniformly dissolved. The oil phase parts were added to the aqueous phase, and (4) dissolved in a part of (1) was added to obtain an emulsion. As the high-molecular silicone, high-molecular-weight dimethylpolysiloxane having a viscosity of 20 cs with R 1 and R 2 being methyl groups, n being 6000 and having a chemical formula of Chemical Formula 2 was used.
【0025】「表1」「表2」及び「表3」の結果よ
り、実施例の皮膚外用剤は、角質除去剤を高分子シリコ
ーンと併用せずに単独に配合した比較例に比べ、角質除
去効果が相乗的に増大し、かつ肌荒れ改善防止効果、保
湿効果、実使用効果においても比較例の比べ優れた結果
を示していることが分かる。From the results of Table 1, Table 2, and Table 3, the skin external preparations of the Examples are superior to the Comparative Example in which the exfoliating agent is not used in combination with the high molecular silicone but is used alone. It can be seen that the removal effect increases synergistically, and that the effect of preventing rough skin improvement, the effect of moisturizing, and the effect of actual use are superior to those of the comparative example.
【0026】[0026]
【発明の効果】本発明によれば、特定の角質除去剤を高
分子シリコーンと組合せることにより、角質除去効果が
増大しかつ優れた肌荒れ改善防止効果及び保湿効果を有
する皮膚外用剤が提供出来る。According to the present invention, by combining a specific exfoliating agent with a high molecular silicone, an external preparation for skin having an increased exfoliating effect and having an excellent effect of preventing and improving skin roughness and an excellent moisturizing effect can be provided. .
Claims (2)
シリコーンの一種または二種以上と、低分子ベタイン、
ヒドロキシカルボン酸若しくはそのエステル、ラクトン
または塩、ケトカルボン酸若しくはそのエステル、ラク
トンまたは塩からなる群から選ばれた角質除去剤の一種
または二種以上とを含有することを特徴とする皮膚外用
剤。 【化1】 (R1はメチル基または一部がフェニル基を表し、R2は
メチル基または水酸基を表す。また、nは、3000〜
20000の整数を表す。)Claims: 1. A high-molecular silicone represented by the following general formula (1), one or more high-molecular silicones,
An external preparation for skin, comprising one or more exfoliants selected from the group consisting of hydroxycarboxylic acids or their esters, lactones or salts, ketocarboxylic acids or their esters, lactones or salts. Embedded image (R 1 represents a methyl group or a part thereof represents a phenyl group, R 2 represents a methyl group or a hydroxyl group.
Represents an integer of 20,000. )
あることを特徴とする請求項1記載の皮膚外用剤。2. The external preparation for skin according to claim 1, wherein the exfoliating agent is trimethylglycine.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP06246597A JP3638395B2 (en) | 1997-02-28 | 1997-02-28 | Topical skin preparation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP06246597A JP3638395B2 (en) | 1997-02-28 | 1997-02-28 | Topical skin preparation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH10245331A true JPH10245331A (en) | 1998-09-14 |
| JP3638395B2 JP3638395B2 (en) | 2005-04-13 |
Family
ID=13200993
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP06246597A Expired - Fee Related JP3638395B2 (en) | 1997-02-28 | 1997-02-28 | Topical skin preparation |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP3638395B2 (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001058938A (en) * | 1999-08-20 | 2001-03-06 | Kose Corp | Cosmetic |
| WO2019112129A1 (en) * | 2017-12-04 | 2019-06-13 | 주식회사 엘지생활건강 | Cosmetic composition for promoting skin exfoliation |
-
1997
- 1997-02-28 JP JP06246597A patent/JP3638395B2/en not_active Expired - Fee Related
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001058938A (en) * | 1999-08-20 | 2001-03-06 | Kose Corp | Cosmetic |
| WO2019112129A1 (en) * | 2017-12-04 | 2019-06-13 | 주식회사 엘지생활건강 | Cosmetic composition for promoting skin exfoliation |
Also Published As
| Publication number | Publication date |
|---|---|
| JP3638395B2 (en) | 2005-04-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0711143B1 (en) | Cosmetic composition containing hydroxyacids | |
| JP3299054B2 (en) | Skin cosmetics | |
| JP3825075B2 (en) | Skin treatment composition | |
| US6008246A (en) | External preparation for skin containing a low-molecular-weight betaine | |
| JP3483988B2 (en) | Skin preparation | |
| JPWO1997002803A1 (en) | topical skin preparations | |
| JP2000327558A (en) | Method for increasing cell rejuvenscence speed | |
| JP3344822B2 (en) | External preparation for skin | |
| CN1501793A (en) | Improved Compositions for Skin | |
| JPH0995432A (en) | Preparation for external use for skin | |
| JPH0995411A (en) | Preparation for external use for skin | |
| JPH10245331A (en) | Preparation for external use for skin | |
| JPH07215839A (en) | Skin external agent | |
| JPH01100114A (en) | External preparation for skin | |
| JPH09263514A (en) | Preparation for external use for skin | |
| JP2003183148A (en) | Skin external preparation composition | |
| JPH115725A (en) | Preparation for external use for skin | |
| JPH07215832A (en) | Skin external preparation | |
| JPH08183725A (en) | Skin cosmetics | |
| JPH10245330A (en) | Preparation for external use for skin | |
| JPH0625053B2 (en) | External skin preparation | |
| JP2006298796A (en) | External preparation for improving fine wrinkle | |
| JPH0995410A (en) | Preparation for external use for skin | |
| JPH09143048A (en) | Dermal agent for external use | |
| JPH05112442A (en) | External preparation of skin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20031226 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20040203 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20040331 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20040512 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20040512 |
|
| A911 | Transfer of reconsideration by examiner before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20040615 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20041109 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20041126 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20050104 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20050111 |
|
| R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080121 Year of fee payment: 3 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090121 Year of fee payment: 4 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090121 Year of fee payment: 4 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100121 Year of fee payment: 5 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100121 Year of fee payment: 5 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110121 Year of fee payment: 6 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120121 Year of fee payment: 7 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130121 Year of fee payment: 8 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130121 Year of fee payment: 8 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |